Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5 (Q9628)
Revision as of 22:00, 20 May 2020 by Admin (talk | contribs) (Created claim: Property:P93: PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model, #quickstatements; #temporary_batch_1590010982689)
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zaidi AH
0 references
2017
0 references
Ann. Surg.
0 references
266
0 references
PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English)
0 references